Webinar

What Med Device Companies Need to Know About Litigating in the ITC

Hosts

ITC veterans Rich Sterba and Karrie Wheatley will explain why medical device companies should also sue in the ITC rather than only in District Court. The webinar will highlight: - The benefits of litigating in the ITC, including a fast pace and unique remedies (cease and desist and exclusion orders) that will stop infringing importations and activity - The requirements of litigating in the ITC, including preparing an ITC complaint and domestic industry considerations - The challenges of litigating in the ITC, including recent opinions from the Commission regarding public interest concerns around excluding medical devices Disclaimer: Closed captioning is automated and may contain errors. You may request an edited transcript at fr.com.

Due to rapid advancements in diagnostics and an aging population, the U.S. medical device market is anticipated to grow from $192.78 billion in 2023 to $291.04 billion by 2030. Roughly a third of the medical devices in the U.S. are imported from abroad. The International Trade Commission offers patent owners the ability to have U.S. Customs and Border Protection stop a competitor's infringing medical device from being imported into the United States.

ITC veterans Rich Sterba and Karrie Wheatley will explain why medical device companies should also sue in the ITC rather than only in District Court. The webinar will highlight:

  • The benefits of litigating in the ITC, including a fast pace and unique remedies (cease and desist and exclusion orders) that will stop infringing importations and activity
  • The requirements of litigating in the ITC, including preparing an ITC complaint and domestic industry considerations
  • The challenges of litigating in the ITC, including recent opinions from the Commission regarding public interest concerns around excluding medical devices

Download a copy of the webinar slides.

If you have any questions, please contact eventsteam@fr.com.